HEREDITARY CANCER SCREENINGS

HEREDITARY CANCER SCREENINGS

Comprehensive Hereditary Cancer Risk Assessment:*

Next Generation Sequencing (NGS) based screening for mutations known to effect an individuals risk of developing hereditary cancer is performed at RMC’S partner affiliates state-of-the-art, CLIA certified facility. RMC’s partner affiliate use The PREDICT test results, along with a treating provider’s expertise to make better informed treatment and/or monitoring decisions.

COMMON HEREDITARY CANCERS AND CANCER SYNDROMES

  • Lynch Syndrome (MLH1, MSH2, MSH6, PMS2, EPCAM)
  • Colon Cancer (APC, BMPR1A, EPCAM)
  • Uterine Cancer (MLH1, MSH2, EPCAM, MSH6, PMS2)
  • Endometrial Cancer (EPCAM, MLH1, MSH2, MSH6)
  • Li-Fraumeni Syndrome (TP53)
  • Breast and Ovarian Cancer (BRCA1, BRCA2)
*Corporate partner affiliate information. Please contact RMC for corporate partner’s information.
Rego Medical Consultants is not a health care provider. All statements contained herein are informational and for educational purposes only and are not intended to influence a health care provider’s judgment in treating patients. All decisions relating to the use of any health care product or service are to be solely made by an appropriately licensed health care provider and the patient.